🇯🇵·17h agoIndustry
血友病A治療薬ヘムライブラを創製した中外製薬の研究者3名が世界的権威のある米国の科学賞「ラスカー賞」を受賞 ～独自の着想で治療体系を変えたバイスペシフィック抗体の発明が評価～
Publisher
C
Chugai Pharmaceutical News
Japan
This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Chugai Pharmaceutical News
- Region
- Japan
- Scope
- Industry
- Published
- September 9, 2026
Publisher context, original article off-platform
This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.
Source route
Continue on chugai-pharm.co.jp
Leave the platform to read the original full article on the publisher site.
Source: Chugai Pharmaceutical News
Scope: Industry
Related coverage
More related coverage
Certara/7h ago
Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development
<![CDATA[Intermountain Health Newsroom]]>/8h ago
New Intermountain Health Flight & Ambulance Services Base at Intermountain St. George Regional Hospital to Save Response Time and Enhance Patient Care
Certara/10h ago
Tailwinds for MIDD: EMA, FDA, and a Converging Regulatory Landscape
NeoGenomics/11h ago